Overview

Vorinostat and Palliative Radiotherapy

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Phase I study. Side-effects when combined with standard palliative radiotherapy.
Phase:
Phase 1
Details
Lead Sponsor:
Oslo University Hospital
Treatments:
Histone Deacetylase Inhibitors
Vorinostat